Royal Bank of Canada’s Jaguar Health JAGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$0 Sell
20
-2
-9% -$44 ﹤0.01% 7400
2025
Q4
$1K Hold
22
﹤0.01% 7002
2025
Q3
$2K Hold
22
﹤0.01% 6885
2025
Q2
$2K Hold
22
﹤0.01% 6801
2025
Q1
$3K Buy
+22
New +$12.4K ﹤0.01% 6496
2024
Q2
Hold
0
7293
2024
Q1
Hold
0
7286
2023
Q4
Hold
0
7346
2023
Q3
Hold
0
7323
2023
Q2
Hold
0
7441
2023
Q1
Hold
0
7266
2022
Q4
Hold
0
7464
2022
Q3
Hold
0
7639
2022
Q2
Hold
0
7538
2022
Q1
Hold
0
7877
2021
Q4
Hold
0
7780
2021
Q2
Hold
0
7576
2021
Q1
Hold
0
7550

Other funds holding JAGX

Royal Bank of Canada's JAGX Position: Q1 2026 in Review

Royal Bank of Canada reduced its Jaguar Health (JAGX) stake by 9.1% in Q1 2026, selling an estimated $44 and leaving 20 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #7400.

Royal Bank of Canada first reported a position in JAGX in Q1 2025 and has held it in 5 quarters since. The position peaked at $3K in Q1 2025. 10 funds tracked by Wall St. Rank hold JAGX as of Q1 2026.

  • Royal Bank of Canada held 20 shares of Jaguar Health worth $0 as of Q1 2026.
  • Royal Bank of Canada sold 2 Jaguar Health shares in Q1 2026, an estimated $44.
  • Jaguar Health made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #7400 holding.
  • Royal Bank of Canada first reported a position in Jaguar Health in Q1 2025 and has held it in 5 quarters since.
  • Royal Bank of Canada's Jaguar Health position peaked at $3K in Q1 2025.
  • 10 funds tracked by Wall St. Rank held Jaguar Health as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.